Rhein Induces Oral Cancer Cell Apoptosis and ROS via Suppresse AKT/mTOR Signaling Pathway In Vitro and In Vivo
International Journal of Molecular Sciences · 09.05.2023 · 24 (10) · 8507
DOI: 10.3390/ijms24108507 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 09.05.2023. Verfasst von Haibo Zhang und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Animal Science and Biotechnology, Kyungpook National University, Sangju 37224, Republic of Korea. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-akt, Mouth Neoplasms. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Basic Science Research Program.
Abstract (Originalsprache)
Oral cancer remains the leading cause of death worldwide. Rhein is a natural compound extracted from the traditional Chinese herbal medicine rhubarb, which has demonstrated therapeutic effects in various cancers. However, the specific effects of rhein on oral cancer are still unclear. This study aimed to investigate the potential anticancer activity and underlying mechanisms of rhein in oral cancer cells. The antigrowth effect of rhein in oral cancer cells was estimated by cell proliferation, soft agar colony formation, migration, and invasion assay. The cell cycle and apoptosis were detected by flow cytometry. The underlying mechanism of rhein in oral cancer cells was explored by immunoblotting. The in vivo anticancer effect was evaluated by oral cancer xenografts. Rhein significantly inhibited oral cancer cell growth by inducing apoptosis and S-phase cell cycle arrest. Rhein inhibited oral cancer cell migration and invasion through the regulation of epithelial–mesenchymal transition-related proteins. Rhein induced reactive oxygen species (ROS) accumulation in oral cancer cells to inhibit the AKT/mTOR signaling pathway. Rhein exerted anticancer activity in vitro and in vivo by inducing oral cancer cell apoptosis and ROS via the AKT/mTOR signaling pathway in oral cancer. Rhein is a potential therapeutic drug for oral cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Animal Science and Biotechnology, Kyungpook National University, Sangju 37224, Republic of Korea.
- Department of Animal Biotechnology, Research Center for Horse Industry, Kyungpook National University, Sangju 37224, Republic of Korea.
- College of Pharmacy, Henan University of Chinese Medicine, Zhengzhou 450046, China.
- School of Animal Life Convergence Science, Hankyung National University, Anseong 17579, Republic of Korea.
- School of Life Sciences, BK21 FOUR KNU Creative BioResearch Group, Kyungpook National University, Daegu 41566, Republic of Korea.
- Department of Dental Hygiene, Kyungpook National University, Sangju 37224, Republic of Korea.
ORCID-Profile: Junkoo Yi, Muhammad Atif Raza, Sijun Park, Soyoung Jang, Kirim Kim, Youngkyun Lee
Förderung
- Basic Science Research Program
Zitieren
APA
Zhang, H., Ma, L., Kim, E., Yi, J., Huang, H., Kim, H., Raza, M. A., Park, S., Jang, S., Kim, K., Kim, S. H., Lee, Y., Kim, E., Ryoo, Z. Y., & Kim, M. O. (2023). Rhein Induces Oral Cancer Cell Apoptosis and ROS via Suppresse AKT/mTOR Signaling Pathway In Vitro and In Vivo. International Journal of Molecular Sciences, 24(10), 8507. https://doi.org/10.3390/ijms24108507
Vancouver
Zhang H, Ma L, Kim E, Yi J, Huang H, Kim H, et al. Rhein Induces Oral Cancer Cell Apoptosis and ROS via Suppresse AKT/mTOR Signaling Pathway In Vitro and In Vivo. International Journal of Molecular Sciences. 2023;24(10):8507. doi:10.3390/ijms24108507
BibTeX
@article{Zhang2023,
author = {Zhang, Haibo and Ma, Lei and Kim, Eungyung and Yi, Junkoo and Huang, Hai and Kim, Hyeonjin and Raza, Muhammad Atif and Park, Sijun and Jang, Soyoung and Kim, Kirim and Kim, Sung-Hyun and Lee, Youngkyun and Kim, Eunkyong and Ryoo, Zae Young and Kim, Myoung Ok},
title = {Rhein Induces Oral Cancer Cell Apoptosis and ROS via Suppresse AKT/mTOR Signaling Pathway In Vitro and In Vivo},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {10},
pages = {8507},
doi = {10.3390/ijms24108507}
}
EUVIMED